Search Results
Jun 16, 2026, 09:00 ET Archer Meat Snacks Launches First-Ever Chicken Protein Snack, Expanding to Target and Walmart with New 8-Count Multipack Line
no artificial ingredientsBrand growth: Archer dollar sales up 34.3% in the latest 52 weeks vs. 9.2% category growth (SPINS, total US ending 3/22/26); meat stick sales specifically up 54.9% vs. category 16.1%. Archer is outpacing meat stick category growth by more than 3x"Archer was
More news about: Archer
Jun 16, 2026, 09:00 ET State of Logistics Report Finds Volatility is the New Normal Shaping Global Supply Chains, Requiring Continuous Adaptation
remains uneven by shippers and logistics providers across the supply chain, with a large gap between companies that have placed AI into core workflows vs. those still restricted to isolated point solutions, with many having none at all.Companies are responding to labor constraints with accelerated
More news about: Penske Logistics
Jun 16, 2026, 08:31 ET BRAMI Italian Protein Pasta Partners with the New York Yankees for the 2026 Season
the following ways:LED signage placements visible during games and broadcastsSpecial group-ticket event on August 11 vs. Seattle. Each group ticket purchased through this
More news about: BRAMI
Jun 16, 2026, 08:00 ET ARNICARE® BY BOIRON PARTNERS WITH FORMER MLS STAR SÉBASTIEN LE TOUX TO SPOTLIGHT PERFORMANCE RECOVERY
Brand to host media and influencers at MetLife Stadium during France vs. Senegal match as recovery takes center stage during soccer's biggest momentNEWTOWN SQUARE, Pa., June 16, 2026 /PRNewswire/ -- As global
More news about: Boiron USA
Jun 16, 2026, 08:00 ET Florence Healthcare Unlocks Agentic AI Across Global Site Network at DIA 2026
training compliance or site-level workflows that are blocking study activation.Study Progress: Providing a real-time summary of "Expected vs. Actual" document completion and personnel readiness."The administrative burden on both sites and sponsors is the single greatest bottleneck
More news about: Florence Healthcare
Jun 16, 2026, 08:00 ET Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference
has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized (designed as non-inferiority vs vancomycin), primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. With mutually consistent
More news about: Acurx Pharmaceuticals, Inc.
Jun 16, 2026, 07:04 ET Affle Announces Strategic Acquisition of AdColony Technology Assets and Trademark from DT
wide and diverse range of mobile publisher connections globally. Affle's deep verticalization strategy and expanded IP portfolio ensure enhanced human-vs-non-human data distillation to drive premium consumer conversions through its differentiated CPCU (Cost Per Converted User) business model."We
More news about: Affle
Jun 16, 2026, 06:07 ET ADMA Court Deadline: ADMA Biologics Investors are Notified of the Important August 10 Deadline in the Pending Securities Fraud Class Action Lawsuit
firm, published a report titled "ADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and –3% Real Growth in 2025 vs. +20% Reported." The report revealed, among other things, that in 2025 ADMA induced one of its distributors to "stock excess ASCENIV by offering rebates
More news about: Bleichmar Fonti & Auld LLP
Jun 15, 2026, 14:18 ET Linha de lava e seca da LG une alta capacidade e tamanho compacto para otimizar o espaço nas lavanderias
reorganizou suas operações em quatro divisões de negócios: Home Appliance Solution (HS), Media Entertainment Solution (MS), Vehicle Solution (VS) e Eco Solution (ES), redefinindo seus papéis e identidades para acelerar sua visão de futuro até 2030. Em 2024, as quatro divisões combinadas
More news about: LG Electronics Brasil
Jun 15, 2026, 14:00 ET HelloNation Reviews Recreational vs Competitive Gymnastics Difference Featuring Gymnastics Expert Rebecca Marson of Crystal Coast Gymnastics
a HelloNation article that explores the recreational vs competitive gymnastics difference and what families should consider before making a commitment.
More news about: HelloNation
Jun 15, 2026, 14:00 ET L2T Announces GEO Tactics and LLM Reporting to Drive Dealership Visibility in AI Search
keyword strategy and citation countReferral traffic from leading LLMsBrand sentiment in AI search resultsAI market share vs. competitorsPrompt visibilityA Unified Approach to SEO and GEO:L2T integrates GEO into its SEO packages, helping dealerships
More news about: L2T
Jun 15, 2026, 12:44 ET The Discovery Point Difference: Choosing Center-Based VPK vs. Public School Programs
multimedia:https://www.prnewswire.com/news-releases/the-discovery-point-difference-choosing-center-based-vpk-vs-public-school-programs-302800561.htmlSOURCE
More news about: Discovery Point Franchising, Inc
Jun 15, 2026, 12:00 ET AI Leadership vs. Hype: XPRIZE CEO Anousheh Ansari on Building What Matters
multimedia:https://www.prnewswire.com/news-releases/ai-leadership-vs-hype-xprize-ceo-anousheh-ansari-on-building-what-matters-302781504.htmlSOURCE
More news about: Planet Classroom Network
Jun 15, 2026, 11:00 ET Affle Announces Strategic Acquisition of AdColony Technology Assets and Trademark from DT
wide and diverse range of mobile publisher connections globally. Affle's deep verticalization strategy and expanded IP portfolio ensure enhanced human-vs-non-human data distillation to drive premium consumer conversions through its differentiated CPCU (Cost Per Converted User) business model."We
More news about: Affle
Jun 15, 2026, 10:40 ET Sleep Apnea Expert Dr. Robert Spoont Examines CPAP Therapy vs Oral Appliance Therapy in HelloNation
CPAP vs Oral Appliance Therapy: What's the Difference? features insights from Dr. Robert Spoont, Sleep Apnea Expert of Boca Raton, Florida, in HelloNation.About
More news about: HelloNation
Jun 15, 2026, 10:01 ET Laser Welding Machine Market Accelerates EV Battery Production and Smart Manufacturing Growth| CAGR 6.2% Says Persistence Market Research
GoodsBy Power ScaleLow Power (<1 kW)Medium Power (1–4 kW)High Power (>4 kW)Pulse Vs Continuous ModesMulti-Mode/Adaptive Power SystemsBy RegionNorth AmericaEuropeEast
More news about: Persistence Market Research Pvt. Ltd.
Jun 15, 2026, 09:37 ET Lakefront Living Myths and Realities Examined in HelloNation by Real Estate Network Expert Chris Thayer
Myth vs. Fact: Lakefront Living in Monticello, Indiana, is available on HelloNation. In this article, Real Estate Network Expert Chris Thayer of Monticello
More news about: HelloNation
Jun 15, 2026, 09:15 ET Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
pre-specified subgroups, including patients with IDH-wild-type and IDH-mutant tumors. Other key secondary endpoints, including disease control rate (54% vs 27.5%), and delay to deterioration in pain and physical function, further supported the clinical benefit observed with ozekibart.Ozekibart was
More news about: Inhibrx Biosciences, Inc.
Jun 15, 2026, 08:31 ET SSFF & ASIA 2026 Concludes Award Ceremony in Tokyo, Unveiling Key Industry Trends Across AI and Vertical Cinema
functioned as a high-profile forum highlighting major industry-defining announcements and future-focused cinematic trends. Human Imagination vs. Generative Tech: The AI Debate Aligned with this year's festival theme, "Cinema Engineering," the intersection of artificial intelligence and human
More news about: Short Shorts Film Festival & Asia
Jun 15, 2026, 04:00 ET AI reshapes global labour market into two distinct paths, rewarding human skills: PwC 2026 Global AI Jobs Barometer
non-experts to perform)Companies most able to use AI are seeing faster headcount growth than the least AI-exposed companies (52% vs 36%) and higher wage growth (24% vs 17%)"Super-star companies" most exposed to AI achieved labour productivity gains of 163%, significantly outpacing other businessesJobs requiring specific
More news about: PwC
Jun 15, 2026, 01:00 ET AI reshapes global labour market into two distinct paths, rewarding human skills: PwC 2026 Global AI Jobs Barometer
non-experts to perform)Companies most able to use AI are seeing faster headcount growth than the least AI-exposed companies (52% vs 36%) and higher wage growth (24% vs 17%)"Super-star companies" most exposed to AI achieved labour productivity gains of 163%, significantly outpacing other businessesJobs requiring specific
More news about: PwC
Jun 14, 2026, 21:25 ET 【EHA2026】亞盛醫藥多項臨床數據亮相，彰顯血液腫瘤領域全球創新實力
(PS1728)第一作者：文冰冰，深圳市第二人民醫院關鍵信息：這是一項前瞻性、多中心對照試驗，納入105例既往接受≥2種TKI治療≥18個月但未達MMR的CML-CP患者，按1:2分配至奧雷巴替尼組（40mg隔日口服）或繼續原TKI治療組。結果顯示，6個月時奧雷巴替尼組MMR率顯著高於對照組（54.3% vs 10.0%，P<0.001）；12個月時累積MMR率分別為57.14%和21.43%（P<0.0001）。最常見3-4級血液學不良事件為血小板減少（42.86%）和貧血（17.14%），非血液學事件罕見。78.57%的患者在換用奧雷巴替尼後，既往TKI相關AE得到改善。結論支持奧雷巴替尼作為≥2種TKI治療失敗CML-CP患者的潛在標準治療。UPDATED
More news about: 亞盛醫藥
Jun 14, 2026, 13:10 ET Grupo Menarini relata dados do Ensaio SENTRY de Fase 3 de Selinexor Plus Ruxolitinibe em mielofibrose no Congresso da Associação Europeia de Hematologia (EHA) 2026
desfecho co-primário demonstrando uma melhora estatisticamente significativa da redução do volume do baço (SVR35) de 49,8% para o braço de combinação vs 28% para o braço de controle na semana 24.A análise post-hoc do estudo SENTRY de fase 3 sugere que o SVR35 pode prever a sobrevida global
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 14, 2026, 07:26 ET Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24.Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS);
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 13, 2026, 06:33 ET New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma
15.9%) were significantly higher for Tal-DP and Tal-D vs DPd, respectively, after two years median follow-up.1 Clinically meaningful improvement in OS was shown with Tal-DP (HR, 0.47; 95% CI, 0.30-0.73) and Tal-D (HR, 0.51; 95% CI, 0.33-0.78) vs DPd. At 24 months, Tal-DP delivered an OS rate of
More news about: Johnson & Johnson